Semaglutide shows promise as a potential alcohol use disorder medication Intramural scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA), and collaborators from The Scripps Research Institute, found that semaglutide reduces alcohol consumption and binge-like drinking in a rodent model of alcohol misuse
Expect possible out-of-pocket costs These medications can be costly, so planning is important
Saykin, H
Beyond weight loss: the emerging role of incretin-based treatments in cardiometabolic HFpEF
And Jim, just recently, a couple days ago, and we're going to need to do a whole episode on it, there was a, I think, a Cleveland Clinic analysis that showed decreased progression of metastatic cancer and, you know, several different kinds of cancers, meaning decreased metastatic disease, which is huge